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This study aimed to evaluate environmental air sampling as an alternative form of active
surveillance for respiratory pathogens in clinical settings. Samples were collected from
three locations in the Emergency Department at Duke University Hospital Systems from
October 2017 to March 2018. Of the 44 samples collected, 12 were positive for known
respiratory pathogens including influenza A, influenza D, and adenovirus. Results suggest
bioaerosol sampling may serve as a complement to active surveillance in clinical settings.
Additionally, since respiratory viruses were detected in aerosol samples, our results
suggest that hospital infection control measures, including the use of N95 respirators,
could be used to limit the spread of infectious viruses in the air.
Keywords: infectious aerosols, bioaerosol sampling, emergency service, hospital, epidemiology, respiratory
viruses
INTRODUCTION
Emergency Departments (ED) are often at the frontline of clinical care for many who are seriously
ill, unable to be seen acutely by a primary care provider, or are uninsured (1). Particularly
during respiratory virus and seasonal influenza outbreaks, EDs are tasked with the evaluation and
treatment of sick individuals. As there is increasing evidence to suggest that respiratory viruses
may be transmitted in air (2–4), novel surveillance targeting bioaerosols has been suggested as a
non-invasive clinical sampling technique (5).
In this pilot study, we studied bioaerosol samples collected in the ED for molecular evidence of
respiratory viruses. Our overall goal was to determine if environmental air sampling was a viable
alternate method for respiratory virus surveillance in clinical settings.
MATERIALS AND METHODS
Ethics Approval and Study Location
This study was granted exemption from review status by the Institutional Review Board at
Duke University on the grounds that the research did not directly involve contact with human
subjects. Permission from the clinical supervisor at Duke Emergency Department was obtained
Choi et al. Aerosol Sampling in a Hospital Emergency Room
and collaboration with the on-duty care providers was ensured
in order to conduct this study at Duke University Hospital
Emergency Department.
Bioaerosol Sampling
Bioaerosol sampling at Duke Hospital ED was conducted by
study personnel once a week from October 4th 2017 to March
1st 2018, excluding a 6-week holiday period from the beginning
of December 2017 to mid-January 2018. In total, 15 separate
sampling periods yielded 44 aerosol samples to be tested for the
panel of viruses.
Environmental air was circulated through National Institute
of Occupational Safety and Health (NIOSH) BC 251 Personal
Aerosol Samplers by AirCheck XR5000 Sample Pumps (Cat. #
210-5000, SKC, Inc., Eighty-Four, PA). Each NIOSH Sampler
featured two stages of collection for pathogens greater than 4
and 1–4µm in size, and a polytetrafluoroethylene (PTFE) back-
up filter (0.03µm pore, 37mm) to capture pathogens less than
1µm, producing three specimens for each sampler during each
run. Pathogens filtered greater than 4µm and 1–4µm had the
potential for remaining viable after capture.
The samplers were placed 1.5m above the ground,
approximately at eye-level for seated visitors, at three locations
within the ED. Two samplers were placed in the Duke ED
waiting room, one at each of the North and South wings of the
ED waiting room seating area. The third sampler was set-up in
one of the available triage rooms (1, 2, or 3) used for the rapid
assessment of patient symptoms. The sampling pumps were
calibrated to a flow rate of 3.5 L/min and ran for approximately
100–150min during each sampling session. At the end of the
sampling session, the location of sampling was recorded with the
data, time, sampler number, pump number, and run time.
Sample Processing
Upon completion of the sampling period, all bioaerosol samplers
were transported back to the Duke One Health Research
Laboratory (located in an adjacent building in the medical
complex). The filter and catchment containers were processed as
previously described (5). Briefly, filter and catchment containers
were removed from the samplers, rinsed with a sterile virus
collection medium (PBS with 0.5% BSA) and aliquoted into
2.0mL cryovials for storage. Samples were stored at −80◦C until
further molecular work was performed.
Molecular Assays
We focused this pilot study surveillance upon four groups of
prevalent respiratory viruses, human and animal. Published real-
time polymerase chain reaction (qPCR) and real-time reverse
transcription polymerase chain reaction (qRT-PCR) assays
for influenza A/B/C/D viruses, human adenoviruses, human
enteroviruses, and human coronavirus were used with DNA
or cDNA positive controls and nuclease-free water as negative
controls (Table S1).
Extraction of viral RNA from the stored samples was
completed using the QIAmp Viral RNA Mini Kit (QIAGEN,
Inc., Valencia, CA) and tested with qRT-PCR assays using
Superscript R© III Platinum One-Step qRT-PCR System with
Platinum R© Taq DNA Polymerase (Thermo Fisher Scientific, Inc.,
Waltham, MA) for detection of Influenza A (6, 7), influenza B (6,
8), influenza C (9), influenza D (6), human coronavirus (10, 11),
and human enterovirus (10). Pan-species coronaviruses (10) were
detected with gel-based RT-PCR assays using Superscript R© III
Platinum One-Step RT-PCR System with Platinum R© Taq DNA
Polymerase (Thermo Fisher Scientific, Inc., Waltham, MA).
For the analysis of specimens for adenovirus (11), viral DNA
was extracted using the QIAampDNABloodMini Kit (QIAGEN,
Inc. Valencia, CA) and then examined by a real time PCR
(qPCR) assay (12) using the Sso Advanced Universal Probes
Supermix (Bio-Rad, Hercules, CA). Positive specimens were then
confirmed using previously described two step molecular assays
focusing on the hexon gene (13). Extracted viral DNA was also
tested with for detection of pan-species adenovirus (14) with
Platinum R© Taq DNA Polymerase Kit (Thermo Fisher Scientific
Inc., Waltham, MA). Amplified product from both the hexon
assay and the pan-species assay was submitted to Eton Bioscience
(Eton Bioscience, Inc., Raleigh, NC, USA) for sequencing. Using
BioEdit 7.1.9 (Ibis Biosciences, Carlsband, CA, USA) sequences
were aligned, edited, and then compared to the National Center
for Biotechnology Information (NCBI) sequence database using
the BLAST application.
RESULTS
From October 2017 to March 2018, a total of 44 bioaerosol
samples were collected from three sites in the emergency room
of Duke hospital. Overall, 12 (27%) of the 44 samples indicated
evidence of at least one respiratory pathogen over a period of
8 different sample collection days (Table 1). One sample was
positive for influenza A virus (2%), one was positive for influenza
D virus, and 10 (23%) samples were positive for adenovirus.
Five of the 10 adenovirus positive specimens were successfully
sequenced using partial hexon sequencing and found to be either
human adenovirus type 1, 7, or 21, as reported in Table 2.
Adenoviruses were detectedmost frequently in the North wing of
the ED waiting room seating area, with 5 (11%) positive samples
detected in that area.
DISCUSSION
In this pilot study, we conducted aerosol surveillance for
human and potentially zoonotic respiratory viruses in a hospital
emergency room setting. Respiratory viruses were detected in
27% of aerosol samples. Additionally, one aerosol sample had
molecular evidence of influenza D virus, which is likely a rare
event. Through our surveillance, we were able to detect molecular
evidence of respiratory pathogens in aerosol samples through
non-invasive environmental sampling techniques. Although
traditional surveillance methods rely heavily on laboratory
testing and clinical reports of disease activity (1), recent
publications have indicated that this type of aerosol and personal
sampling method may be valid as in field settings (15, 16).
Similar to Wang et al. (17), our surveillance detected the
presence of adenoviruses in aerosol samples (17). As these viruses
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TABLE 1 | Molecular results for three sites in the emergency department at Duke University Hospital, October 2017 to February 2018.
Sample ID Date Site FluA FluB FluC FluD AdV PanAdV CoV PanCoV
DM-BS013 10/4/2017 North – – – – – – – –
DM-BS014 10/4/2017 South – – – – – – – –
DM-BS015 10/4/2017 Triage 1 – – – – – – – –
DM-BS016 10/10/2017 South – – – – – – – –
DM-BS017 10/10/2017 North – – – – – – – –
DM-BS018 10/10/2017 Triage 1 – – – – – – – –
DM-BS019 10/17/2017 North – – – – – – – –
DM-BS020 10/17/2017 South – – – – – – – –
DM-BS021 10/17/2017 Triage 1 – – – – – – – –
DM-BS022 10/24/2017 North – – – – + – – –
DM-BS023 10/24/2017 South – – – – + – – –
DM-BS024 10/24/2017 Triage 1 – – – – + – – –
DM-BS025 10/31/2017 North – – – – + – – –
DM-BS026 10/31/2017 South – – – – + – – –
DM-BS027 10/31/2017 Triage 1 – – – – – – – –
DM-BS028 11/7/2017 South – – – – – – – –
DM-BS029 11/7/2017 North – – – – – – – –
DM-BS030 11/7/2017 Triage 2 – – – – – – – -
DM-BS031 11/14/2017 North – – – – – – – –
DM-BS032 11/14/2017 Triage 3 – – – + – – – –
DM-BS033 11/14/2017 South – – – – – – – –
DM-BS034 11/21/2017 North – – – – + – – –
DM-BS035 11/21/2017 South – – – – – – – –
DM-BS036 11/21/2017 Triage 2 – – – – – – – –
DM-BS037 11/28/2017 North – – – – + – – –
DM-BS038 11/28/2017 South – – – – – – – –
DM-BS039 11/28/2017 Triage 1 – – – – – – – –
DM-BS040 1/25/2018 Triage 2 – – – – – – – –
DM-BS041 1/25/2018 North – – – – – – – –
DM-BS042 1/25/2018 South – – – – – – – –
DM-BS043 2/1/2018 Triage 1 – – – – + – – –
DM-BS044 2/1/2018 South – – – – – – – –
DM-BS045 2/1/2018 North – – – – – – – –
DM-BS046 2/8/2018 South – – – – – – – –
DM-BS047 2/8/2018 North – – – – + – – –
DM-BS048 2/8/2018 Triage 2 – – – – – – – –
DM-BS049 2/15/2018 North – – – – – – – –
DM-BS050 2/15/2018 South – – – – + – – –
DM-BS051 2/15/2018 Triage 2 – – – – – – – –
DM-BS052 2/22/2018 North – – – – – – – –
DM-BS053 2/22/2018 South + – – – – – – –
DM-BS054 2/22/2018 Triage 2 – – – – – – – –
DM-BS055 3/1/2018 South – – – – – – – –
DM-BS056 3/1/2018 North – – – – – – – –
DM-BS057 3/1/2018 Triage 2 – – – – – – – –
FluA, influenza A virus; FluB, influenza B virus; FluC, influenza C virus; FluD, influenza D virus; AdV, adenovirus; CoV, coronavirus.
are relatively hardy DNA viruses, this finding was not unexpected
as adenoviruses may circulate during respiratory virus season.
Despite the use of pan-species molecular detection methods, we
did not find evidence of novel or zoonotic viruses; however,
as we detected influenza A and D viruses, the possibility of
zoonotic viruses cannot be excluded. Despite this, given our
limited number of aerosol samples, over a short period of time, it
is likely that we lacked the sample size to detect airborne zoonotic
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TABLE 2 | Typing results for positive adenovirus specimens.
Sample Human adenovirus type NCBI accession number
DM-BS022 Type 7 KU145089.1
DM-BS023 Type 1 MF085399.1
DM-BS024 Type 7 KU145089.1
DM-BS025 Type 1 MF085396.1
DM-BS037 Type 21 KM677954.1
viruses in a hospital setting. While we found the molecular
detection of influenza D virus in a single aerosol sample
very interesting, without further validation through culture or
sequencing validation, or similar detections among clinically ill
patients, we do not interpret the influenza D detection as worthy
of public health attention.
This pilot study was limited in that we could not link aerosol
results with individual patient illness or patient density seen in
the ED. Although the ED did report patients with respiratory
illness, and in particular influenza A and B, during the sampling
period, we were not able to temporally link our findings with
those patients. Additionally, although not the focus of our study,
we did not detect viable viruses associated with positive aerosol
samples in the ED.
Despite these limitations, the results of this study indicate
that aerosol sampling is a useful complement to traditional
sampling methods. Our finding that 27% of collected aerosol
samples showed molecular evidence for at least one respiratory
pathogen suggests that patients waiting in the emergency room
are shedding virus in aerosolized droplets. As this method is
non-invasive and relatively low in cost, there are advantages
to environmental sampling techniques in high density areas,
such as the emergency room, where direct patient sampling is
difficult or not possible. Additionally, as this and other studies
have demonstrated the ability to molecularly detect airborne
viruses in hospital waiting room infection control procedures
such as the use of N95 respirators for sick patients should be
considered. This information on the molecular detection of
respiratory viruses in hospital aerosols can be used to inform
hospital practice on prevention and spread of infection in waiting
rooms. Further study on the transmission of viruses in the air
is needed to determine potential for infection with airborne
particles in this type of setting.
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